About Readline
Readline is a company based in Shenzhen (China) founded in 2013 by Jian Liu. Readline has raised $143.22 million across 3 funding rounds from investors including Gree, Jinhong Holding Group and Oriental Fortune Capital. Readline offers products and services including Efficacy Care Raw Materials and Biomedicine Peptides.
- Headquarter Shenzhen, China
- Founders Jian Liu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 深圳瑞德林生物技术有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$143.22 M (USD)
in 3 rounds
-
Latest Funding Round
$68.92 M (USD), Series C
Feb 24, 2025
-
Investors
Gree
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Readline
Readline offers a comprehensive portfolio of products and services, including Efficacy Care Raw Materials and Biomedicine Peptides.
Green production of bioactive raw materials for skincare is achieved to support health and beauty applications.
Scale production of peptide drugs using synthetic biology is accomplished to aid in the treatment of chronic diseases.
Funding Insights of Readline
Readline has successfully raised a total of $143.22M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $68.92 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Readline
Readline has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include Gree, Jinhong Holding Group and Oriental Fortune Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by Oriental Fortune Capital.
|
Locked | Locked | Locked | |
|
Early- and growth-stage investments are directed toward hard technology sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Readline
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Readline
Investment portfolio details for Readline
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Readline
Detailed financials for Readline
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Readline Comparisons
Peer comparison for Readline
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Readline
Detailed competitors of Readline
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Readline
Complete news archive for Readline
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Readline
Readline was founded in 2013 and raised its 1st funding round 8 years after it was founded.
Readline is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Readline is a funded company, having raised a total of $143.22M across 3 funding rounds to date.
Readline was founded in 2013 in Shenzhen, China, as an RD firm specializing in peptides. Manufacturing and exporting of peptides for cosmetic, pharmaceutical, and amino acid uses are conducted by the company. Operations occur within the biotechnology sector, with a focus on research, production, and international distribution. The firm is led by co-founder Jian Liu, serving global markets from its base in China.
Readline offers Efficacy Care Raw Materials and Biomedicine Peptides.
Readline has 17 investors. Key investors include Gree, Jinhong Holding Group, Oriental Fortune Capital, Green Pine Capital Partners, and Hunan caixin Investment Holding Group.